Literature DB >> 19190937

What do we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease.

Guy H Neild1.   

Abstract

Congenital abnormalities of the kidney and urinary tract (CAKUT) account for more than half of all renal failure in children. For young adults with CAKUT two questions are paramount: what is the prognosis and what is the best management to improve outcome? The paediatric literature shows that prognostic factors are glomerular filtration rate (GFR) and the presence of proteinuria. We reviewed data from 101 young adult patients with either primary vesico-ureteric reflux and renal dysplasia or obstructive uropathy. Patients had an estimated GFR (eGFR) of <or=60 ml/min per 1.73 m(2) body surface area and had had at least 5 years of follow up (median 162 months). There was a strong correlation between the amount of proteinuria at the start and overall rate of decline. Angiotensin-converting enzyme inhibitors (ACEIs) slowed declining renal function at all levels of function, but this only had a significant effect on renal outcome when eGFR was >35 ml/min. The ACEI benefit increased with time. Rate of decline was slower than reported for other diseases and was only -2.4 ml/min per year for those reaching the start of dialysis. Outcome is predictable by the level of residual renal function (GFR). Nevertheless, function remains stable while proteinuria is minimal. Short-term studies overestimate rates of deterioration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190937     DOI: 10.1007/s00467-008-1107-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

Review 1.  Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group.

Authors:  A S Levey; T Greene; G J Beck; A W Caggiula; J W Kusek; L G Hunsicker; S Klahr
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

2.  Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

Authors: 
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

3.  Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.

Authors:  W A Wilmer; L A Hebert; E J Lewis; R D Rohde; F Whittier; D Cattran; A S Levey; J B Lewis; S Spitalewitz; S Blumenthal; R P Bain
Journal:  Am J Kidney Dis       Date:  1999-08       Impact factor: 8.860

4.  In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia.

Authors:  P Ruggenenti; A Perna; R Benini; T Bertani; C Zoccali; Q Maggiore; M Salvadori; G Remuzzi
Journal:  J Am Soc Nephrol       Date:  1999-05       Impact factor: 10.121

5.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Authors:  Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

6.  Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.

Authors:  H H Parving; P Rossing; E Hommel; U M Smidt
Journal:  Am J Kidney Dis       Date:  1995-07       Impact factor: 8.860

7.  Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.

Authors:  Elke Wühl; Otto Mehls; Franz Schaefer
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

8.  Reflux nephropathy and chronic atrophic pyelonephritis: a review.

Authors:  P Kincaid-Smith; G Becker
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

9.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11

10.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

View more
  13 in total

1.  No difference in meeting hemoglobin and albumin targets for dialyzed children with urologic disorders.

Authors:  Rachel M Lestz; Meredith Atkinson; Barbara Fivush; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2011-03-20       Impact factor: 3.714

2.  Combination of pediatric and adult formulas yield valid glomerular filtration rate estimates in young adults with a history of pediatric chronic kidney disease.

Authors:  Derek K Ng; George J Schwartz; Michael F Schneider; Susan L Furth; Bradley A Warady
Journal:  Kidney Int       Date:  2018-05-05       Impact factor: 10.612

3.  Renal Parenchymal Area Growth Curves for Children 0 to 10 Months Old.

Authors:  Katherine Fischer; Chunming Li; Huixuan Wang; Yihua Song; Susan Furth; Gregory E Tasian
Journal:  J Urol       Date:  2016-02-28       Impact factor: 7.450

4.  Urinary tract infection pattern in adult women followed from childhood.

Authors:  Carin Gebäck; Sverker Hansson; Jeanette Martinell; Torsten Sandberg; Ulf Jodal
Journal:  Pediatr Nephrol       Date:  2016-02-15       Impact factor: 3.714

5.  Renal parenchymal area and risk of ESRD in boys with posterior urethral valves.

Authors:  Jose E Pulido; Susan L Furth; Stephen A Zderic; Douglas A Canning; Gregory E Tasian
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

Review 6.  Current perspectives on congenital obstructive nephropathy.

Authors:  Susan E Ingraham; Kirk M McHugh
Journal:  Pediatr Nephrol       Date:  2011-02-17       Impact factor: 3.714

7.  Aberrant Differentiation of Human Pluripotent Stem Cell-Derived Kidney Precursor Cells inside Mouse Vascularized Bioreactors.

Authors:  Parisa Ranjzad; Jessica Jinks; Amir P Salahi; Ioannis Bantounas; Brian Derby; Susan J Kimber; Adrian S Woolf; Jason K F Wong
Journal:  Nephron       Date:  2020-08-05       Impact factor: 2.847

8.  Chronic kidney disease in children: A report from a tertiary care center over 11 years.

Authors:  Alaleh Gheissari; Saeedeh Hemmatzadeh; Alireza Merrikhi; Sharareh Fadaei Tehrani; Yahya Madihi
Journal:  J Nephropathol       Date:  2012-10-01

9.  Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract.

Authors:  Elke Wühl; Karlijn J van Stralen; Enrico Verrina; Anna Bjerre; Christoph Wanner; James Goya Heaf; Oscar Zurriaga; Andries Hoitsma; Patrick Niaudet; Runolfur Palsson; Pietro Ravani; Kitty J Jager; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 8.237

Review 10.  What do we know about chronic renal failure in young adults? I. Primary renal disease.

Authors:  Guy H Neild
Journal:  Pediatr Nephrol       Date:  2009-02-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.